ReviewFrontiers in microbiology2022
COPD and Gut-Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics.
Ling Qu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
68 papers cite itlatest 60 shown
this paperpooled ittrialcites it